British Columbia Cancer Agency clinical trial pipeline

9 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 4 with minor changes only.

1. Notable

   PEGASUS · Monitoring and Managing Glucose Levels · Pancreatic…PEGASUS · Monitoring and Managing Glucose Levels · Pancreatic Cancer

   Primary and study completion pushed from Apr 2027 to Oct 2028

   Also in this update: Primary endpoint(s) modified; Interventions modified

   British Columbia Cancer Agency·Not applicable· NCT05132244· Registry history of NCT05132244 on ClinicalTrials.gov (opens the registry)

   Updated Sep 14, 2026

2. Notable

   PanGen · Prospectively Defining Metastatic Pancreatic Ductal…PanGen · Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

   Primary completion pushed from Dec 2026 to Dec 2027

   Also in this update: Completion pushed from Dec 2027 to Dec 2028

   British Columbia Cancer Agency·Not specified· NCT02869802· Registry history of NCT02869802 on ClinicalTrials.gov (opens the registry)

   Updated Sep 14, 2026

3. Notable

   CAPTIV-8 · Atezolizumab in People Whose Tumour DNA or RNA…CAPTIV-8 · Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

   Primary endpoint(s) modified

   Also in this update: Enrollment reduced: 200 → 50 participants; Trial arms changed: 8 → 3

   British Columbia Cancer Agency·Phase 2· NCT04273061· Registry history of NCT04273061 on ClinicalTrials.gov (opens the registry)

   Updated Sep 16, 2026

4. Notable

   PanFit · Using Strength Tests to Better Understand How Pancreatic…PanFit · Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life

   Recruitment opened

   British Columbia Cancer Agency·Not applicable· NCT07255001· Registry history of NCT07255001 on ClinicalTrials.gov (opens the registry)

   Updated Sep 15, 2026

5. Notable

   Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

   Primary completion date changed from estimate of Dec 2025 to Aug 2026

   Also in this update: Completion pushed from Jul 2026 to Jul 2027

   British Columbia Cancer Agency·Not applicable· NCT02933242· Registry history of NCT02933242 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.